You are most probably aware how ERP for pharma industry in Uganda helps businesses in many ways like automating, simplifying communication between departments, helping in being compliant, and many more, but today we will discuss how ERP systems can also help in stopping counterfeits in Uganda’s pharma industry.
The pharmaceutical industry in Uganda faces a serious threat from copyright drugs, which impacts both public health as well as the business in many different ways. If we look at the stats, the World Health Organization (WHO) estimates that nearly 10% of medicines in low and middle-income countries are copyright, and Uganda is no exception. copyright medicines contain incorrect amounts of ingredients, improper dosages, or sometimes even harmful substances. Instead of treating the condition, they interfere with the drug’s effectiveness, which in some cases results in the patient’s death.
For pharmaceutical companies, copyright drugs not only harm patients but also damage brand reputation and erode consumer trust. When patients experience negative outcomes from fake medications, they also lose confidence in original products, which affects the company’s long-term business growth. Financial losses due to copyright drugs are significant as fake products infiltrate the supply chain, leading to returns and regulatory penalties.
The Ugandan government, through the National Drug Authority (NDA), has introduced measures to combat copyright drugs, but the complexity of the supply chain makes it very hard to track and eliminate them completely.
To address these complex challenges, you need an ERP for pharma industry in Uganda that provides real-time visibility, authentication tools, and compliance management, which collectively help in fighting counterfeits. ERP solutions empower pharma companies to secure their supply chains, ensure product authenticity, and rebuild consumer trust.
Before discussing how an intelligent ERP software can solve these challenges in the most effective way, let us first explore some of the complex Challenges of copyright Drugs in Uganda.